Home
Search
BIO Investor Forum Digital   |   October 19-21, 2021

Speakers & Presenters

Below is the current list of confirmed speakers and presenters for the BIO Investor Forum Digital. More speakers will be added in the lead up to the event, so check back regularly for updates. 

Featured Speakers
Cartier Esham, PhD
Cartier Esham, PHD
EVP, ECS AND SVP, SCIENCE AND REGULATORY, BIOTECHNOLOGY INNOVATION ORGANIZATION
Cartier Esham serves as Executive Vice President for Emerging Companies at the Biotechnology Innovation Organization (BIO). In this role, Dr. Esham…
Jung-Chi Liao
Jung-Chi Liao
FOUNDER, SYNCELL
Founder, SYNCELL INC. 2020-present. Research Fellow, 2019-present, Academia Sinica. Associate Research Fellow, 2014-2019, Academia Sinica. …
Patrizia Cavazzoni
Patrizia Cavazzoni, MD
DEPUTY DIRECTOR FOR OPERATIONS, CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), U.S. FOOD AND DRUG ADMINISTRATION (FDA)
Patrizia Cavazzoni, M.D., is the Deputy Director for Operations at FDA’s Center for Drug Evaluation and Research (CDER). In this position, Dr…
Cartier Esham, PhD
Jung-Chi Liao
Patrizia Cavazzoni
All Speakers
By Count | Alphabetical
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
photo
Anne-Marie Carbonell, MD
CO-FOUNDER & CEO, ONCOSYNERGY, INC.
OncoSynergy, Inc
Greenwich, Connecticut, United States
photo
Will Chou
CEO, ARUVANT SCIENCES, INC.
Aruvant
New York, New York, United States
photo
Denis Dufrane, PHD, MD
CEO & FOUNDER, NOVADIP BIOSCIENCES SA
NOVADIP Biosciences sa
Mont-Saint-Guibert, Belgium
photo
Lynn Durham
CEO & FOUNDER, STALICLA SA
STALICLA S.A.
Geneva, Switzerland
photo
Cartier Esham, PHD
EVP, ECS AND SVP, SCIENCE AND REGULATORY, BIOTECHNOLOGY INNOVATION ORGANIZATION
Fireside Chat: Patrizia Cavazzoni, MD, Acting Director for Center for Drug Evaluation and Research (CDER) and Deputy Center Director for Operations, U.S. Food and Drug Administration (FDA)
Washington, District of Columbia, United States
photo
Charles Fisher , PHD, BS
FOUNDER AND CEO , UNLEARN.AI
Digital Health and AI-Generated Digital Twins in Clinical Trials
Unlearn.AI
San Francisco, California, United States
photo
Yue Liu
PRESIDENT, AB STUDIO, INC.
Ab Studio, Inc.
Hayward, California, United States
photo
Wang Yip Darren Lui, CFA, CA, BSC
PRESIDENT AND EXECUTIVE DIRECTOR, APTORUM GROUP LTD.
Aptorum Group Limited
London, United Kingdom
photo
Sabrina Martucci Johnson
PRESIDENT & CEO, DARé BIOSCIENCE
Daré Bioscience
San Diego, California, United States
photo
David Thomas
VICE PRESIDENT, INDUSTRY RESEARCH, BIOTECHNOLOGY INNOVATION ORGANIZATION
BIO's State of VC Investment Trends
Washington, District of Columbia, United States
photo
Shruti Abbato
EVP, BUSINESS DEVELOPMENT, MAXCYTE, INC.
CARMA Cell Therapies
Gaithersburg, Maryland, United States
photo
Joe Abdo II, PHD, MS
CHIEF EXECUTIVE OFFICER, STELLA DIAGNOSTICS, INC.
Stella Diagnostics, Inc.
New York, New York, United States
photo
Srinivas Akkaraju, MD, PHD
FOUNDER AND MANAGING GENERAL PARTNER, SAMSARA BIOCAPITAL
U.S. Election Outlook: Presidential & Congressional Scenario Planning for Biopharma Priorities
Palo Alto, California, United States
photo
Mert Aktar
VICE PRESIDENT AND HEAD OF CORPORATE DEVELOPMENT, KITE, A GILEAD COMPANY
Fireside Chat: How Kite Pharma Is Building Out The Promise Of CAR-T To Transform Cancer Treatment
photo
Brandon Allgood
SVP, DATA SCIENCE & AI, VALO HEALTH
AI's Widening Impact on Drug Development
San Francisco, California, United States
photo
Susan Angele
SENIOR ADVISOR, KPMG LLP
Achieving Corporate Diversity and Inclusion Goals through Investment and Policy Choices
Montvale, New Jersey, United States
photo
James Antonopoulos, JD
MANAGING DIRECTOR, HEAD OF HEALTHCARE INVESTMENT BANKING, ROTH CAPITAL PARTNERS, LLC
Fireside Chat: Nisa Leung, Qiming Venture Partners and James Antonopoulos, ROTH Capital Partners on Cross-Pacific Investment Perspectives
New York, New York, United States
photo
Robert Arathoon, PHD
FOUNDER AND CHIEF EXECUTIVE OFFICER, KENJOCKETY BIOTECHNOLOGY, INC
Kenjockety Biotechnology, Inc
South San Francisco, California, United States
photo
Jan Aronsen
DR., SPARK JAN ARONSEN
SPARK Jan Aronsen
Oslo, Norway
photo
Phyllis Arthur
VICE PRESIDENT, INFECTIOUS DISEASES AND DIAGNOSTICS POLICY, BIOTECHNOLOGY INNOVATION ORGANIZATION
Treating Infectious Diseases: Lessons from COVID-19 and Avoiding Future Pandemics
Washington, District of Columbia, United States
photo
David Arthur
CHIEF EXECUTIVE OFFICER, SALARIUS PHARMACEUTICALS
Salarius Pharmaceuticals, Inc
Houston, Texas, United States
photo
Shahid Azim
CEO , REACT NEURO
REACT Neuro
Cambridge, Massachusetts, United States
photo
Jonathan Baker, PHD
SENIOR TECHNOLOGY MANAGER, MONTANA BIOSCIENCE ALLIANCE
TechLink/Department of Veterans Affairs/Department of Defense
Bozeman, Montana, United States
photo
Jianxin Bao, PHD
CEO, GATEWAY BIOTECHNOLOGY INC.
Gateway Biotechnology
Saint Louis, Missouri, United States
photo
Dror Bashan
PRESIDENT & CEO, PROTALIX BIOTHERAPEUTICS
Protalix BioTherapeutics
Karmiel, Israel
photo
Piraye Beim, PHD
CHIEF EXECUTIVE OFFICER, CELMATIX, INC.
Celmatix
New York, New York, United States
photo
Abhijit Bhatia, MBA, MS
VICE PRESIDENT OF GLOBAL CORPORATE & BUSINESS DEVELOPMENT, RAKUTEN MEDICAL, INC.
Rakuten Medical
San Diego, California, United States
photo
Barbara Bierer
FACULTY DIRECTOR, MRCT CENTER OF HARVARD AND BWH
Addressing Racism and Disparities during Therapeutic Development and in the Clinic
Cambridge, Massachusetts, United States
photo
Igor Bilinsky, PHD
CHIEF BUSINESS OFFICER, ONCTERNAL THERAPEUTICS
Oncternal Therapeutics
San Diego, California, United States
photo
Montserrat Biosca
CEO, NANOLIGENT SL
Nanoligent SL
Bellaterra (Barcelona), Spain
photo
Greg Bosch, MBA
CHIEF EXECUTIVE OFFICER, GEISTLICH PHARMA NORTH AMERICA, INC
Geistlich Pharma
Princeton, New Jersey, United States
photo
Martin Bott
INTERIM GENERAL MANAGER, AMR ACTION FUND
The New AMR Action Fund to Invest in Antibiotic Development
Carmel, Indiana, United States
photo
Janice Bourque, MBA
MANAGING DIRECTOR, HERCULES CAPITAL
Market Outlook: Solid Ground or Thin Ice?
Boston, Massachusetts, United States
photo
Melissa Bradford-Klug
CHIEF BUSINESS OFFICER, CITRINE MEDICINE
China Deal-Making Now: New Opportunities and Barriers
Cambridge, Massachusetts, United States
photo
Christopher Bradley, MSC
CEO, LOKI THERAPEUTICS
Loki Therapeutics
Long Island City, New York, United States
photo
Ross Breckenridge, PHD, MD
CEO, ARJUNA THERAPEUTICS
ARJUNA Therapeutics
Santiago de Compostela, Spain
photo
Paul Brennan, MSC, BSC
PRESIDENT & CEO, NERVGEN PHARMA
NervGen Pharma Corp.
Vancouver, British Columbia, Canada
photo
Rod Bugawan
BUSINESS DEVELOPMENT MANAGER, NOVOTECH (AUSTRALIA) PTY LIMITED
Novotech
San Francisco, California, United States
photo
Charles "Chuck" Calderaro
SENIOR VICE PRESIDENT AND GLOBAL HEAD OF TECHNICAL OPERATIONS, KITE, A GILEAD COMPANY
Fireside Chat: How Kite Pharma Is Building Out The Promise Of CAR-T To Transform Cancer Treatment
photo
Diana Caldwell
CEO AND PRESIDENT, AMPLIFIED SCIENCES, LLC
Amplified Sciences
West Lafayette, Indiana, United States
photo
Ray Camphausen, PHD
CEO, WAYLAND BIOTHERAPEUTICS, LLC
Wayland Biotherapeutics LLC
Wayland, Massachusetts, United States
photo
Anne-Marie Carbonell, MD
CO-FOUNDER AND CEO, ONCOSYNERGY
Trends in New Oncology Target Treatments
photo
Karen Carey
NEWS ANALYST, BIOWORLD TODAY
Conducting Remote Clinical Trials Productively During a Pandemic
York, Pennsylvania, United States
photo
John Carpten
PROFESSOR AND CHAIR OF TRANSLATIONAL GENOMICS;DIRECTOR, INSTITUTE OF TRANSLATIONAL GENOMICS, KECK SCHOOL OF MEDICINE, USC
Addressing Racism and Disparities during Therapeutic Development and in the Clinic
Los Angeles, California, United States
photo
Patrizia Cavazzoni, MD
DEPUTY DIRECTOR FOR OPERATIONS, CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), U.S. FOOD AND DRUG ADMINISTRATION (FDA)
Fireside Chat: Patrizia Cavazzoni, MD, Acting Director for Center for Drug Evaluation and Research (CDER) and Deputy Center Director for Operations, U.S. Food and Drug Administration (FDA)
Silver Spring, Maryland, United States
photo
Howard Chen
MANAGING PRINCIPAL, MANAGEMENT CONSULTING, IQVIA CHINA
China Deal-Making Now: New Opportunities and Barriers
Jing'an District, Shanghai, China
photo
Jung Choi
CHIEF BUSINESS & STRATEGY OFFICER, GLOBAL BLOOD THERAPEUTICS
Addressing Racism and Disparities during Therapeutic Development and in the Clinic
South San Francisco, California, United States
photo
Guy Cipriani
CBO, MICROBION CORPORATION
Microbion Corporation
Bozeman, Montana, United States
photo
Steve Clemons
EDITOR-AT-LARGE, THE HILL
Biotech's Finest Hour: Progress Update on BIO Policy Work and COVID-19
Washington, District of Columbia, United States
photo
Matt Coffey
CEO, ONCOLYTICS BIOTECH
Oncolytics Biotech
Calgary, Alberta, Canada
photo
Asha Collins, PHD
HEAD OF COUNTRY CLINICAL OPERATIONS, GENENTECH, A MEMBER OF THE ROCHE GROUP
Addressing Racism and Disparities during Therapeutic Development and in the Clinic
South San Francisco, California, United States
photo
Grace Colon, PHD
PRESIDENT & CEO, INCARDA THERAPEUTICS INC.
Achieving Corporate Diversity and Inclusion Goals through Investment and Policy Choices
Newark, California, United States
photo
David Coman
CEO, SCIENCE 37
Conducting Remote Clinical Trials Productively During a Pandemic
Los Angeles, California, United States
photo
Kevin Conroy, JD
CHAIRMAN AND CEO, EXACT SCIENCES CORPORATION
New Directions in Diagnostics Innovation
Madison, Wisconsin, United States
photo
Pamela Contag, PHD
CHIEF EXECUTIVE OFFICER, BIOECLIPSE THERAPEUTICS, INC.
BioEclipse Therapeutics
Mountain View, California, United States
photo
Helena Cowley, MBA, MS
CEO, OXIDIEN PHARMACEUTICALS, LLC
Oxidien Pharmaceuticals
Gainesville, Florida, United States
photo
David Crean, PHD, MBA
MANAGING DIRECTOR, OBJECTIVE CAPITAL PARTNERS, LLC
View from the Board: Managing Teams During a Pandemic
San Diego, California, United States
photo
William Crossman
PRESIDENT & CEO, PHOENIX PHARMALABS, INC
Phoenix PharmaLabs, Inc.
Woods Cross, Utah, United States
photo
Max Cynader
CEO, PRIMARY PEPTIDES INC
Primary Peptides Inc
Vancouver, British Columbia, Canada
photo
Matthew David
EVP, CHIEF FINANCIAL OFFICER, CORMEDIX INC.
CorMedix
Berkeley Heights, New Jersey, United States
photo
Atul Deshpande, PHD, MBA, PMP
CHIEF STRATEGY OFFICER AND HEAD, US OPERATIONS, HARBOUR BIOMED
Harbour BioMed
Cambridge, Massachusetts, United States
photo
Gini Deshpande, PHD
CEO, NUMEDII, INC.
AI's Widening Impact on Drug Development
Menlo Park, California, United States
photo
Brett Dines, MBA, BPHARM
CEO, OYE THERAPEUTICS INC
OYE Therapeutics, Inc
Crown Point, Indiana, United States
photo
Daniel Dornbusch
CEO, EXCISION BIOTHERAPEUTICS
Excision BioTherapeutics
Oakland, California, United States
photo
Jakob Dupont, MD
EXECUTIVE VP & GLOBAL HEAD OF R&D, ATARA BIOTHERAPEUTICS
Atara Biotherapeutics, Inc.
South San Francisco, California, United States
photo
Michael Edwards
PRESIDENT, HARBINS RUHR BIOSCIENCE, INC.
Harbins Ruhr Bioscience, Inc.
Wilson, Wyoming, United States
photo
Mark Emalfarb
CHIEF EXECUTIVE OFFICER, DYADIC INTERNATIONAL, INC
Dyadic International, Inc.
Jupiter, Florida, United States
photo
Steven Engle
CEO, COHBAR INC.
CohBar, Inc.
Menlo Park, California, United States
photo
Timothy Enns
PRESIDENT & CEO, NANOVALENT PHARMACEUTICALS, INC
NanoValent Pharmaceuticals Inc
Pleasanton, California, United States
photo
Anna Eriksrud
CEO, NEODYNAMICS AB
NeoDynamics AB (publ)
Lidingo, Stockholm, Sweden
photo
Joseph Evans, PHD
CEO & PRESIDENT, PLEIOGENIX
Pleiogenix
Carlsbad, California, United States
photo
Robert Fallon
PRESIDENT & CEO, PHOSPLATIN THERAPEUTICS
Phosplatin Therapeutics
New York, New York, United States
photo
Justin Field
SVP, GOVERNMENT AFFAIRS, NVCA
U.S. Election Outlook: Presidential & Congressional Scenario Planning for Biopharma Priorities
Washington, District of Columbia, United States
photo
Karen Flynn
PRESIDENT, BIOLOGICS AND CHIEF COMMERCIAL OFFICER, CATALENT BIOLOGICS
Fireside Chat: Catalent's Karen Flynn and Supply Chain Contingencies to Avoid Upheavals
Somerset, New Jersey, United States
photo
Gregory Frank, PHD
SENIOR DIRECTOR, INFECTIOUS DISEASE POLICY, BIOTECHNOLOGY INNOVATION ORGANIZATION
The New AMR Action Fund to Invest in Antibiotic Development
Washington, District of Columbia, United States
photo
Steven Fruchtman, MD
PRESIDENT & CEO, ONCONOVA THERAPEUTICS, INC.
Onconova Therapeutics, Inc.
Newtown, Pennsylvania, United States
photo
Jeffrey Galvin
CHIEF EXECUTIVE OFFICER, AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC.
American Gene Technologies
Rockville, Maryland, United States
photo
Ricardo Garcia
CEO | FOUNDER, ONCOHEROES BIOSCIENCIES INC.
Oncoheroes Biosciences Inc.
Brookline, Massachusetts, United States
photo
Julie Gerberding, MD, MPH
EXECUTIVE VICE PRESIDENT AND CHIEF PATIENT OFFICER, STRATEGIC COMMUNICATIONS, GLOBAL PUBLIC POLICY, MERCK
Treating Infectious Diseases: Lessons from COVID-19 and Avoiding Future Pandemics
Gwynedd, Pennsylvania, United States
photo
Bill Gerhart
CEO, RESPIVANT SCIENCES, INC.
Conducting Remote Clinical Trials Productively During a Pandemic
San Diego, California, United States
photo
Geno Germano
PRESIDENT & CHIEF EXECUTIVE OFFICER, ELUCIDA ONCOLOGY, INC
Elucida Oncology
Monmouth Junction, New Jersey, United States
photo
Simba Gill
VENTURE PARTNER;PRESIDENT AND CEO, FLAGSHIP PIONEERING;EVELO
Treating Infectious Diseases: Lessons from COVID-19 and Avoiding Future Pandemics
photo
L. Michael Glodé
PRESIDENT, AURORA ONCOLOGY
Aurora Oncology
Golden, Colorado, United States
photo
Manijeh Goldberg, PHD
CEO, PRIVO TECHNOLOGIES
Privo Technologies Inc
Peabody, Massachusetts, United States
photo
Guy Goldberg
CHIEF BUSINESS OFFICER, REDHILL BIOPHARMA
RedHill Biopharma
Raleigh, North Carolina, United States
photo
Asthika Goonewardene
MANAGING DIRECTOR, EQUITY RESEARCH — BIOTECH, TRUIST SECURITIES
Trends in New Oncology Target Treatments
New York, New York, United States
photo
Adam Goulburn
PARTNER, LUX CAPITAL
Conducting Remote Clinical Trials Productively During a Pandemic
photo
Carla Grandori, PHD, MD
CO-FOUNDER & CEO, SENGINE PRECISION MEDICINE
SEngine Precision Medicine
Seattle, Washington, United States
photo
Jacqueline Grant
PRINCIPAL, ABINGWORTH
Achieving Corporate Diversity and Inclusion Goals through Investment and Policy Choices
Boston, Massachusetts, United States
photo
Kevin Grimes, MD, MBA, FACP
PROFESSOR OF CHEMICAL & SYSTEMS BIOLOGY, STANFORD UNIVERSITY
New Resources to Accelerate Translational Research
Stanford, California, United States
photo
Irene Griswold-Prenner, PHD
CHIEF EXECUTIVE OFFICER & CSO, NITROME BIOSCIENCES, INC.
How to Pivot Neurodegeneration Treatment Research?
Brisbane, California, United States
photo
Gunnveig Grodeland, PHD, MSC
DR., UNIVERSITY OF OSLO
SPARK Norway
Oslo, Norway
photo
Jonas Grossman
PARTNER AND PRESIDENT, CHARDAN
SPACs: Advantages and Disadvantages Versus Normal IPO
photo
Kenneth Gruber
PRESIDENT/CSO, TENSIVE CONTROLS
Tensive Controls, Inc.
Columbia, Missouri, United States
photo
Al Guillem
CEO, ONCONANO MEDICINE, INC.
OncoNano Medicine, Inc.
Southlake, Texas, United States
photo
Sonia Gupta
MANAGING DIRECTOR, GOLDMAN SACHS & CO.
Achieving Corporate Diversity and Inclusion Goals through Investment and Policy Choices
New York, New York, United States
photo
James Hackworth, PHD
PRESIDENT, PARK THERAPEUTICS, INC.
Park Therapeutics
Morristown, New Jersey, United States
photo
Sean Hall, MD
CEO, MEDLAB
Medlab Clinical Limited
Sydney, New South Wales, Australia
photo
Dror Harats, MD
CHIEF EXECUTIVE OFFICER, VASCULAR BIOGENICS LTD.
Vascular Biogenics Ltd
Modi'in, Israel
photo
Dennis He
DIRECTOR – LIFE SCIENCE/HEALTHCARE, SILICON VALLEY BANK
BIO's State of VC Investment Trends
San Diego, California, United States
photo
James Healy, PHD, MD
GENERAL PARTNER, SOFINNOVA VENTURES, INC.
Market Outlook: Solid Ground or Thin Ice?
Menlo Park, California, United States
photo
Abraham Heifets
CEO, ATOMWISE, INC.
AI's Widening Impact on Drug Development
San Francisco, California, United States
photo
Jay Heller
HEAD OF CAPITAL MARKETS, NASDAQ
SPACs: Advantages and Disadvantages Versus Normal IPO
New York, New York, United States
photo
Carole Ho, MD
CHIEF MEDICAL OFFICER, DENALI THERAPEUTICS INC.
How to Pivot Neurodegeneration Treatment Research?
South San Francisco, California, United States
photo
Ken Horne
PRESIDENT & COO, TEON THERAPEUTICS, INC.
Teon Therapeutics, Inc.
Redwood City, California, United States
photo
Tao Huang
VENTURE PARTNER, CENOVA CAPITAL
China Deal-Making Now: New Opportunities and Barriers
San Carlos, California, United States
photo
Thomas Hudson, MD
SENIOR VICE PRESIDENT R&D AND CHIEF SCIENTIFIC OFFICER, ABBVIE
Trends in New Oncology Target Treatments
North Chicago, Illinois, United States
photo
Brady Huggett
SENIOR EDITOR, NATURE PUBLISHING GROUP
Achieving Corporate Diversity and Inclusion Goals through Investment and Policy Choices
New York, New York, United States
photo
Tom Isett
CEO, IBIO, INC.
iBio, Inc.
New York, New York, United States
photo
Tero Jarvinen
PROFESSOR, TAMPERE UNIVERSITY
SPARK Finland - DecoDerma
Tampere, Finland
photo
Ramesh Jayaraman, MESC
CSO, THERAINDX LIFESCIENCES PVT LTD
OncodynamiX Lifesciences pvt ltd
Bengaluru, Karnataka, India
photo
Alexis Ji
PARTNER, ILLUMINA VENTURES
New Directions in Diagnostics Innovation
Foster City, California, United States
photo
Patrick Jordan, MBA, MA
CEO, MYCOVIA PHARMACEUTICALS, INC.
Mycovia Pharmaceuticals
Durham, North Carolina, United States
photo
Sari Kaganoff
GENERAL MANAGER, CONSULTING, ROCK HEALTH
Digital Health and AI-Generated Digital Twins in Clinical Trials
photo
Rasika Kalamegham
SENIOR GROUP DIRECTOR, US REGULATORY POLICY, GENENTECH, A MEMBER OF THE ROCHE GROUP
Conducting Remote Clinical Trials Productively During a Pandemic
Washington, District of Columbia, United States
photo
Mahesh Karande, MBA
PRESIDENT & CEO, OMEGA THERAPEUTICS (FKA VL42)
View from the Board: Managing Teams During a Pandemic
Cambridge, Massachusetts, United States
photo
Syed Kazmi, PHD, MBA
PRESIDENT & CHIEF EXECUTIVE OFFICER, JUBILANT THERAPEUTICS, INC.
Jubilant Therapeutics Inc
Bedminster, New Jersey, United States
photo
Lawrence Kenyon
PRESIDENT, CEO AND CFO, OUTLOOK THERAPEUTICS
Outlook Therapeutics, Inc.
East Windsor, New Jersey, United States
photo
Michelle Kim-Danely, PHD
SVP OPERATIONS, AUTOBAHN LABS
New Resources to Accelerate Translational Research
Palo Alto, California, United States
photo
Rachel King
FOUNDER & CEO, GLYCOMIMETICS, INC.
U.S. Election Outlook: Presidential & Congressional Scenario Planning for Biopharma Priorities
Rockville, Maryland, United States
photo
Selina Koch, PHD
EXECUTIVE EDITOR, BIOCENTURY INC.
How to Pivot Neurodegeneration Treatment Research?
San Carlos, California, United States
photo
Michael Kokesh
PRESIDENT & CEO, VICARDIA THERAPEUTICS, INC.
ViCardia Therapeutics, Inc.
San Francisco, California, United States
photo
Gautam Kollu
CHIEF COMMERCIAL OFFICER, GRAIL, INC.
New Directions in Diagnostics Innovation
Menlo Park, California, United States
photo
Ella Korets-Smith, MBA, MSC
CHIEF BUSINESS OFFICER, VIRICA BIOTECH
Virica Biotech
Ottawa, Ontario, Canada
photo
Pat Lawman, PHD
CEO, MORPHOGENESIS INC.
Morphogenesis, Inc.
Tampa, Florida, United States
photo
Seth Lederman, MD
CHIEF EXECUTIVE OFFICER, TONIX PHARMACEUTICALS, INC
Tonix Pharmaceuticals Holding Corp.
New York, New York, United States
photo
David Lederman
DIRECTOR, EQUITY CAPITAL MARKETS, CHARDAN CAPITAL MARKETS
Market Outlook: Solid Ground or Thin Ice?
New York, New York, United States
photo
Nisa Leung
MANAGING PARTNER, QIMING VENTURE PARTNERS
Fireside Chat: Nisa Leung, Qiming Venture Partners and James Antonopoulos, ROTH Capital Partners on Cross-Pacific Investment Perspectives
Hong Kong, Hong Kong
photo
Kirsten Leute
PARTNER, OSAGE UNIVERSITY PARTNERS
New Resources to Accelerate Translational Research
photo
Jeremy Levin, DPHIL, MBBCHIR
CHAIRMAN & CEO, OVID THERAPEUTICS INC.
Biotech's Finest Hour: Progress Update on BIO Policy Work and COVID-19
New York, New York, United States
photo
Yun Li
REPORTER, CNBC
SPACs: Advantages and Disadvantages Versus Normal IPO
Englewood Cliffs, New Jersey, United States
photo
Pi-Hui Liang
FOUNDER, NATIONAL TAIWAN UNIVERSITY COLLEGE OF MEDICINE
SPARK Taiwan - ImmunAdd
Taipei, Taiwan
photo
Jung-Chi Liao
FOUNDER, SYNCELL
SYNCELL INC.
Taipei, Taiwan
photo
Mike Liccardo
VP CORP DEV. & CFO, INVESTOR, PARTNER WITH STRAWBERRY CREEK VENTURES, SHAREVAULT
ShareVault
Los Gatos, California, United States
photo
Pedro Lichtinger, MBA
CHAIRMAN & CEO, STARTON THERAPEUTICS
Starton Therapeutics
Paramus, New Jersey, United States
photo
Matt Liddelow, PHARMD, BSC
CEO & MANAGING DIRECTOR, NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD
NeuroScientific Biopharmaceuticals Ltd
Nedlands, Western Australia, Australia
photo
Jeff Livingstone, PhD
CHIEF EXECUTIVE OFFICER, IGIA PHARMACEUTICALS
Igia Pharmaceuticals
Franklin, Massachusetts, United States
photo
Thomas Loarie, MBA
CEO AND CO-FOUNDER, BRYOLOGYX INC.
BryoLogyx Inc.
Danville, California, United States
photo
Michelle Longmire
CEO, MEDABLE
Conducting Remote Clinical Trials Productively During a Pandemic
Palo Alto, California, United States
photo
Kai Lu
PHD, NATIONAL TAIWAN UNIVERSITY COLLEGE OF MEDICINE
SPARK Taiwan
Taipei, Taiwan
photo
Maria Maccecchini, PHD
PRESIDENT & CEO, ANNOVIS BIO, INC.
Annovis Bio, Inc.
Berwyn, Pennsylvania, United States
photo
David Mann
CEO, VASCULAR BIOSCIENCES, INC.
Vascular BioSciences
Goleta, California, United States
photo
Dave Mantus
PRESIDENT US OPERATIONS, PULMOCIDE
Pulmocide
Boston , Massachusetts, United States
photo
Stephanie Marrus, MBA
MANAGING DIRECTOR, ENTREPRENEURSHIP, UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
New Resources to Accelerate Translational Research
San Francisco, California, United States
photo
Tyler Martin, MD
CEO, ADJUVANCE TECHNOLOGIES, INC.
Adjuvance Technologies, Inc.
Lincoln, Nebraska, United States
photo
Trevor Martin
CO-FOUNDER AND CEO, MAMMOTH BIOSCIENCES
New Directions in Diagnostics Innovation
South San Francisco, California, United States
photo
Shinichi Matsumoto, PHD, MD
CHIEF SCIENTIFIC ADVISOR, OTSUKA PHARMACEUTICAL FACTORY, INC.
Otsuka Pharmaceutical Factory, Inc.
Kobe, Japan
photo
Glenn Mattes
PRESIDENT, CHIEF EXECUTIVE OFFICER AND DIRECTOR, TFF PHARMA
TFF Pharmaceuticals, Inc.
Austin, Texas, United States
photo
Mike Mattoon
VICE PRESIDENT, FEDERAL GOVERNMENT RELATIONS, BIOTECHNOLOGY INNOVATION ORGANIZATION
U.S. Election Outlook: Presidential & Congressional Scenario Planning for Biopharma Priorities
Washington, District of Columbia, United States
photo
David Mazzo, PHD
PRESIDENT & CEO, CALADRIUS BIOSCIENCES, INC
Caladrius Biosciences, Inc.
Basking Ridge, New Jersey, United States
photo
Joe McCann
CEO, POINT BIOPHARMA
POINT Biopharma
Toronto, Ontario, Canada
photo
Michelle McMurry-Heath
PRESIDENT AND CEO, BIOTECHNOLOGY INNOVATION ORGANIZATION
Biotech's Finest Hour: Progress Update on BIO Policy Work and COVID-19
Addressing Racism and Disparities during Therapeutic Development and in the Clinic
Washington, District of Columbia, United States
photo
Sara Michelmore
SENIOR VICE PRESIDENT, MACDOUGALL BIOMEDICAL COMMUNICATIONS
Market Outlook: Solid Ground or Thin Ice?
Natick, Massachusetts, United States
photo
Steve Miller, MD
EVP AND CHIEF CLINICAL OFFICER, CIGNA CORPORATION
New Directions in Diagnostics Innovation
Clayton, Missouri, United States
photo
Frank Minella
CEO, PAINQX
PainQx
New York, New York, United States
photo
James Moe, PHD, MBA
PRESIDENT, OLIGOMERIX, INC.
Oligomerix, Inc.
Bronx, New York, United States
photo
Katherine Moortgat
DIRECTOR, ABBVIE INC.
How to Pivot Neurodegeneration Treatment Research?
North Chicago, Illinois, United States
photo
Adi Mor, PHD
CO-FOUNDER AND CEO, CHEMOAMB
Chemomab
Tel Aviv, Israel
photo
Ana Moreno, PHD
CEO, NAVEGA THERAPEUTICS
Navega Therapeutics
San Diego, California, United States
photo
Jodie Morrison
CHIEF EXECUTIVE OFFICER, CADENT THERAPEUTICS
View from the Board: Managing Teams During a Pandemic
Cambridge, Massachusetts, United States
photo
Christopher Myatt, PHD
CEO, MBIO DIAGNOSTICS, INC
MBio Diagnostics | LightDeck
Boulder, Colorado, United States
photo
Reto Naef, PHD
CEO, TOPADUR PHARMA AG
Topadur Pharma AG
Schlieren, Zurich, Switzerland
photo
Sonja Nesbit
MANAGING DIRECTOR GOVERNMENT AFFAIRS, FTI CONSULTING, INC.
U.S. Election Outlook: Presidential & Congressional Scenario Planning for Biopharma Priorities
Washington, District of Columbia, United States
photo
Carolyn Ng, PhD
MANAGING DIRECTOR, VERTEX VENTURES HC
Trends in New Oncology Target Treatments
photo
Daniel O'Connell
PRESIDENT & CEO, ACUMEN PHARMACEUTICALS, INC
Acumen Pharmaceuticals, Inc.
Charlottesville, Virginia, United States
photo
Tim Oldham, PHD
CEO AND MANAGING DIRECTOR, ADALTA PTY LTD.
AdAlta Ltd
Bundoora, Victoria, Australia
photo
Frederic Ors
CFO, IMV INC.
IMV Inc.
Dartmouth, Nova Scotia, Canada
photo
Won Park
PROFESSOR, SPARK/COLORADO/PARKFLAIG
SPARK Colorado - ParkFlaig
Boulder, Colorado, United States
photo
Meagan Parrish
SENIOR EDITOR, PHARMA MANUFACTURING
Fireside Chat: Catalent's Karen Flynn and Supply Chain Contingencies to Avoid Upheavals
photo
Snehal Patel
CHIEF EXECUTIVE OFFICER, GREENWICH LIFESCIENCES
Greenwich LifeSciences
Sugar Land, Texas, United States
photo
Brian Patrick, MBA
PRESIDENT, A2 THERAPEUTICS
A2 Therapeutics
Houston, Texas, United States
photo
Preethy Paul, PHD
PROJECT MANAGER, SPARK PREETHY PAUL
SPARK Preethy Paul
Turku, Finland
photo
Cindy Perettie
CHIEF EXECUTIVE OFFICER, FOUNDATION MEDICINE, INC
New Directions in Diagnostics Innovation
Cambridge, Massachusetts, United States
photo
Jonathan Polak
CHIEF EXECUTIVE, MESENTECH INC.
Mesentech
Vancouver, British Columbia, Canada
photo
Alexander Polinsky, PHD
CHIEF EXECUTIVE OFFICER, ONCOTARTIS, INC.
OncoTartis, Inc.
Buffalo, New York, United States
photo
Konstantin Poukalov
CHIEF BUSINESS OFFICER, PERCEPTIVE ADVISORS, LLC
China Deal-Making Now: New Opportunities and Barriers
New York, New York, United States
photo
Ferran Prat, PHD, JD
SVP, RESEARCH ADMINISTRATION AND INDUSTRY RELATIONS, UNIVERSITY OF TEXAS, MD ANDERSON CANCER CENTER
Trends in New Oncology Target Treatments
Houston, Texas, United States
photo
David Pyrce
CEO, DEVACELL, INC.
DevaCell
San Diego, California, United States
photo
Karthik Ramachandran, PHD
VP & FOUNDER, LIKARDA, LLC
Likarda, LLC
Kansas City, Missouri, United States
photo
Natarajan Ranganathan, PHD
MANAGING DIRECTOR, KIBOW BIOTECH, INC
Kibow Biotech, Inc.
Newtown Square, Pennsylvania, United States
photo
Jeanne Regnante
CHIEF HEALTH EQUITY AND DIVERSITY OFFICER, LUNGEVITY
Addressing Racism and Disparities during Therapeutic Development and in the Clinic
Bethesda, Maryland, United States
photo
Alain Rolland, PHARMD, PHD
EXECUTIVE ADVISOR, VERIMMUNE INC
VerImmune
Baltimore, Maryland, United States
photo
Steve Rowles
PARTNER, MORRISON & FOERSTER LLP
View from the Board: Managing Teams During a Pandemic
San Diego, California, United States
photo
Brian Rye, CFA
SENIOR HEALTH-CARE POLICY ANALYST, BLOOMBERG INTELLIGENCE
U.S. Election Outlook: Presidential & Congressional Scenario Planning for Biopharma Priorities
Washington, District of Columbia, United States
photo
Peter Santa Maria
ASSISTANT PROFESSOR, STANFORD SCHOOL OF MEDICINE
SPARK Stanford University
Stanford University SPARK
Stanford, California, United States
photo
Niranjan Sardesai, PHD
PRESIDENT & CEO, FOUNDER, GENEOS THERAPEUTICS, INC.
View from the Board: Managing Teams During a Pandemic
Plymouth Meeting, Pennsylvania, United States
photo
Jordan Saxe
SENIOR MANAGING DIRECTOR, NASDAQ
Market Outlook: Solid Ground or Thin Ice?
New York, New York, United States
photo
Christopher Schaber, PHD
PRESIDENT & CEO, SOLIGENIX, INC.
Soligenix, Inc.
Princeton, New Jersey, United States
photo
Andrew Schachter
CEO / FOUNDER, AXIOM REAL-TIME METRICS
Conducting Remote Clinical Trials Productively During a Pandemic
Etobicoke, Ontario, Canada
photo
Chris Schelling
CEO AND FOUNDER, ACER THERAPEUTICS INC.
Acer Therapeutics
Newton, Massachusetts, United States
photo
Andrew Schwab
FOUNDER AND MANAGING PARTNER, 5AM VENTURES
Achieving Corporate Diversity and Inclusion Goals through Investment and Policy Choices
Menlo Park, California, United States
photo
Panna Sharma
CEO, PRESIDENT AND DIRECTOR, LANTERN PHARMA
Lantern Pharma
photo
Christi Shaw
CHIEF EXECUTIVE OFFICER, KITE, A GILEAD COMPANY
Fireside Chat: How Kite Pharma Is Building Out The Promise Of CAR-T To Transform Cancer Treatment
photo
Kira Sheinerman
CEO, DIAMIR, LLC
DiamiR
Monmouth Junction, New Jersey, United States
photo
Craig Shimasaki, PHD, MBA
CEO, MOLECULERA LABS
Moleculera Labs
Oklahoma City, Oklahoma, United States
photo
Scott Shively
CHIEF EXECUTIVE OFFICER, NEUMENTUM, INC.
Neumentum, Inc.
Morristown, New Jersey, United States
photo
Sanjay Shukla, MD, MS
PRESIDENT, CEO, ATYR PHARMA, INC.
aTyr Pharma
San Diego, California, United States
photo
George Simeon
CHIEF EXECUTIVE OFFICER, CUREVO, INC.
Curevo Vaccine Inc.
Seattle, Washington, United States
photo
Shawn Singh
CHIEF EXECUTIVE OFFICER, VISTAGEN THERAPEUTICS, INC.
VistaGen Therapeutics, Inc.
South San Francisco, California, United States
photo
Ruchita Sinha
PARTNER, AV8 VENTURES
BIO's State of VC Investment Trends
Palo Alto, California, United States
photo
Mark Sirgo, PHARMD
CHIEF EXECUTIVE OFFICER, ARUNA BIO
Aruna Bio, Inc.
Athens, Georgia, United States
photo
Yochi Slonim
CO-FOUNDER AND CEO, ANIMA BIOTECH INC.
Anima Biotech Inc
Bernardsville, New Jersey, United States
photo
Bob Soh, MD
INVESTMENT MANAGER, BRANDON CAPITAL PARTNERS
New Resources to Accelerate Translational Research
Melbourne, Victoria, Australia
photo
Jonathan Solomon
CEO AND BOARD MEMBER, BIOMX LTD
SPACs: Advantages and Disadvantages Versus Normal IPO
Ness Ziona, Israel
photo
Otello Stampacchia
MANAGING DIRECTOR, OMEGA FUNDS
Treating Infectious Diseases: Lessons from COVID-19 and Avoiding Future Pandemics
Boston, Massachusetts, United States
photo
Shehnaaz Suliman, MD, MBA, MPhil
PRESIDENT AND CHIEF OPERATING OFFICER, ALECTOR, INC.
How to Pivot Neurodegeneration Treatment Research?
photo
Cathy Swindlehurst, PHD
CEO, NOVOMEDIX, LLC
NovoMedix, LLC
San Diego, California, United States
photo
Marco Taglietti, MD
PRESIDENT & CHIEF EXECUTIVE OFFICER, SCYNEXIS, INC.
SCYNEXIS, Inc.
Jersey City, New Jersey, United States
photo
Ken Takeshita, MD
SENIOR VICE PRESIDENT AND GLOBAL HEAD OF CLINICAL DEVELOPMENT, KITE, A GILEAD COMPANY
Fireside Chat: How Kite Pharma Is Building Out The Promise Of CAR-T To Transform Cancer Treatment
photo
Robert Tarran
FOUNDER/CSO, ELDEC PHARMACEUTICALS
Eldec Pharmaceuticals
Chapel Hill, North Carolina, United States
photo
John Temperato
PRESIDENT & CEO, 9 METERS BIOPHARMA, INC.
9 Meters Biopharma, Inc.
Raleigh, North Carolina, United States
photo
Daniel Teper, MBA, PHARMD
CHAIRMAN & CEO, CYTOVIA THERAPEUTICS, INC.
Cytovia Therapeutics
New York, New York, United States
photo
Nikolaos Tezapsidis, PHD
PRESIDENT & CEO, NEUROTEZ, INC.
Neurotez Inc.
BRIDGEWATER, New Jersey, United States
photo
Brian Toglia
LIFE SCIENCE PRACTICE LEADER, HIGGINBOTHAM
Higginbotham
Houston, Texas, United States
photo
Martin Tolar
FOUNDER, PRESIDENT AND CEO, ALZHEON, INC.
How to Pivot Neurodegeneration Treatment Research?
Framingham, Massachusetts, United States
photo
Philip Toleikis, PHD, MSC
PRESIDENT & CEO, SERNOVA CORP.
Sernova Corp.
London, Ontario, Canada
photo
Vuong Trieu, PHD
CEO, ONCOTELIC, INC.
Mateon Therapeutics
Agoura Hills, California, United States
photo
Karen Tuzman, PHD
HEAD, DISCOVERY & PRECLINICAL RESEARCH, BIOCENTURY INC.
AI's Widening Impact on Drug Development
Redwood City, California, United States
photo
Thomas Vasicek, PHD
CEO, GILA THERAPEUTICS, INC.
Gila Therapeutics, Inc.
Minneapolis, Minnesota, United States
photo
Joshua Wang, PHD
CO-FOUNDER & CHIEF SCIENTIFIC OFFICER, VERIMMUNE
VerImmune
Baltimore, Maryland, United States
photo
Andrea Wang
COFOUNDER AND CEO, AHEAD MEDICINE
AHEAD Medicine
Berkeley, California, United States
photo
Zhirui Wang, PHD
PRESIDENT, ROCK IMMUNE LLC
SPARK Colorado - Rock Immune LLC
Denver, Colorado, United States
photo
Raymond Warrell Jr., MD
CEO, ACQUIST THERAPEUTICS, INC.
Acquist Therapeutics, Inc.
Chatham, New Jersey, United States
photo
Ethan Weiss
CARDIOLOGIST AND ASSOCIATE PROFESSOR, UCSF
Treating Infectious Diseases: Lessons from COVID-19 and Avoiding Future Pandemics
San Francisco, California, United States
photo
Steve Welker, MBA
CHIEF BUSINESS DEVELOPMENT OFFICER, AAVOCYTE, INC.
Aavocyte, Inc.
Bellevue, Washington, United States
photo
Blake Wise
CHIEF EXECUTIVE OFFICER, NOVOME BIOTECHNOLOGIES, INC.
Novome Biotechnologies
South San Francisco, California, United States
photo
Rob Wright
CHIEF EDITOR, LIFE SCIENCE LEADER MAGAZINE
Fireside Chat: How Kite Pharma Is Building Out The Promise Of CAR-T To Transform Cancer Treatment
Erie, Pennsylvania, United States
photo
Jinzi Wu, PHD
FOUNDER, CHAIRMAN AND CEO, ASCLETIS PHARMA INC.
China Deal-Making Now: New Opportunities and Barriers
Hangzhou, Zhejiang, China
photo
Kikuo Yasui, MSC
COO, HEARTSEED
Heartseed Inc.
Tokyo, Japan
photo
David Young, MD
CEO, KISOJI BIOTECHNOLOGY INC.
KisoJi Biotechnology Inc.
Montreal, Quebec, Canada
photo
Gang Zeng, PHD
PRESIDENT AND CEO, T-CURE BIOSCIENCE INC.
T-Cure Bioscience
Sherman Oaks, California, United States
photo
Debbie Zhuang
MANAGING DIRECTOR, CLEARVIEW HEALTHCARE PARTNERS
New Directions in Diagnostics Innovation
Newton, Massachusetts, United States
photo
Stevin Zorn, PHD, MS, BS
PRESIDENT AND CEO, MIND IMMUNE
MindImmune Therapeutics Inc.
Salem, Connecticut, United States
Load More